IN2014MN02511A - - Google Patents

Info

Publication number
IN2014MN02511A
IN2014MN02511A IN2511MUN2014A IN2014MN02511A IN 2014MN02511 A IN2014MN02511 A IN 2014MN02511A IN 2511MUN2014 A IN2511MUN2014 A IN 2511MUN2014A IN 2014MN02511 A IN2014MN02511 A IN 2014MN02511A
Authority
IN
India
Prior art keywords
pharmaceutical form
active substance
release
active
emulsifier
Prior art date
Application number
Inventor
Gernot Francas
Karl Heinz PRZYKLENK
Original Assignee
Hennig Arzneimittel Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hennig Arzneimittel Gmbh & Co filed Critical Hennig Arzneimittel Gmbh & Co
Publication of IN2014MN02511A publication Critical patent/IN2014MN02511A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

A pharmaceutical form is described which makes it possible to uniformly release an active substance over an extended period of time. The pharmaceutical form comprises an emulsifier with a polyalkylene oxide structural motif. The pharmaceutical form is suitable for releasing a second active substance alongside the first active substance. A uniform release is achieved even if the two active substances have completely different properties in terms of solubility. A production method for the pharmaceutical form and the use thereof are also described.
IN2511MUN2014 2012-06-25 2013-06-24 IN2014MN02511A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012105512.2A DE102012105512A1 (en) 2012-06-25 2012-06-25 Pharmaceutical form for prolonged release of active ingredients
PCT/EP2013/063163 WO2014001268A1 (en) 2012-06-25 2013-06-24 Pharmaceutical form for extended release of active substances

Publications (1)

Publication Number Publication Date
IN2014MN02511A true IN2014MN02511A (en) 2015-07-17

Family

ID=48670585

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2511MUN2014 IN2014MN02511A (en) 2012-06-25 2013-06-24

Country Status (22)

Country Link
EP (1) EP2863891B1 (en)
KR (1) KR102160837B1 (en)
AU (1) AU2013283474B2 (en)
BR (1) BR112014032583B1 (en)
CA (1) CA2876294C (en)
CO (1) CO7240370A2 (en)
DE (1) DE102012105512A1 (en)
EA (2) EA028064B1 (en)
ES (1) ES2817248T3 (en)
HR (1) HRP20201534T1 (en)
HU (1) HUE050945T2 (en)
IL (1) IL236465B (en)
IN (1) IN2014MN02511A (en)
LT (1) LT2863891T (en)
MX (1) MX371143B (en)
PH (1) PH12014502834A1 (en)
PL (1) PL2863891T3 (en)
PT (1) PT2863891T (en)
RS (1) RS60872B1 (en)
SI (1) SI2863891T1 (en)
UA (1) UA116776C2 (en)
WO (1) WO2014001268A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014306759B2 (en) 2013-08-12 2018-04-26 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
HUE043399T2 (en) * 2014-06-26 2019-08-28 Hennig Arzneimittel Gmbh&Co Kg Medication for treating dizziness due to various causes
EP3169315B1 (en) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
US20160106737A1 (en) 2014-10-20 2016-04-21 Pharmaceutical Manufacturing Research Services, Inc. Extended Release Abuse Deterrent Liquid Fill Dosage Form
KR101625344B1 (en) * 2015-12-21 2016-06-08 주식회사 유영제약 Pharmaceutical compositions comprising celecoxib and duloxetine

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs
DK0996429T3 (en) * 1997-10-27 2003-05-26 Merck Patent Gmbh Solid solutions and solid dispersions in water heavily soluble drugs
US6368622B2 (en) * 1999-01-29 2002-04-09 Abbott Laboratories Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
JP2007517015A (en) * 2003-12-31 2007-06-28 ファイザー・プロダクツ・インク Stabilized pharmaceutical solid composition of low solubility drug, poloxamer and stabilizing polymer
US20050281876A1 (en) * 2004-06-18 2005-12-22 Shun-Por Li Solid dosage form for acid-labile active ingredient
DE102005014141B4 (en) * 2005-03-23 2006-12-21 Hennig Arzneimittel Gmbh & Co. Kg Tablet-shaped delayed-release preparation against dizziness
WO2007056078A2 (en) 2005-11-02 2007-05-18 Cytokinetics, Inc. Certain chemical entities, compositions, and methods
WO2007086078A2 (en) * 2006-01-30 2007-08-02 Panacea Biotec Ltd. Novel pharmaceutical compositions and process of preparation thereof
CN101049309A (en) * 2006-04-03 2007-10-10 陈茜 Cinnarizine drop pills, and preparation method
AU2008303129B2 (en) * 2007-09-25 2013-08-01 Formulex Pharma Innovations Ltd. Compositions comprising lipophilic active compounds and method for their preparation
WO2009074609A1 (en) * 2007-12-12 2009-06-18 Basf Se Salts of active ingredients with polymeric counter-ions
CA2763837A1 (en) * 2009-06-11 2010-12-16 Photocure Asa Solid compositions comprising 5-aminolevulinic acid
WO2011024029A1 (en) * 2009-08-24 2011-03-03 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Fast disintegrating dosage forms of cinnarizine and dimenhydrinate combination
DE102011051304A1 (en) * 2011-06-24 2012-12-27 Hennig Arzneimittel Gmbh & Co. Kg drug matrix
DE102011051308A1 (en) * 2011-06-24 2012-12-27 Hennig Arzneimittel Gmbh & Co. Kg Manufacturing process and dosage form
DE102011053068A1 (en) * 2011-08-29 2013-02-28 Hennig Arzneimittel Gmbh & Co. Kg Dosage form with stabilized active substance particles

Also Published As

Publication number Publication date
EA035815B1 (en) 2020-08-14
KR20150041612A (en) 2015-04-16
PH12014502834B1 (en) 2015-02-02
EP2863891B1 (en) 2020-08-26
BR112014032583B1 (en) 2022-05-17
LT2863891T (en) 2020-12-10
PT2863891T (en) 2020-09-25
DE102012105512A1 (en) 2014-04-24
CA2876294C (en) 2020-09-08
UA116776C2 (en) 2018-05-10
EA201792143A1 (en) 2018-05-31
IL236465A0 (en) 2015-02-26
AU2013283474B2 (en) 2017-12-14
EA028064B1 (en) 2017-10-31
WO2014001268A1 (en) 2014-01-03
EP2863891A1 (en) 2015-04-29
CO7240370A2 (en) 2015-04-17
RS60872B1 (en) 2020-11-30
BR112014032583A2 (en) 2017-06-27
SI2863891T1 (en) 2020-11-30
PL2863891T3 (en) 2021-01-25
BR112014032583A8 (en) 2021-06-22
PH12014502834A1 (en) 2015-02-02
MX2014015642A (en) 2015-08-05
EA201500043A1 (en) 2015-09-30
HRP20201534T1 (en) 2021-02-19
ES2817248T3 (en) 2021-04-06
AU2013283474A1 (en) 2015-01-29
MX371143B (en) 2020-01-20
KR102160837B1 (en) 2020-09-29
IL236465B (en) 2020-06-30
HUE050945T2 (en) 2021-01-28
CA2876294A1 (en) 2014-01-03

Similar Documents

Publication Publication Date Title
PH12014502834B1 (en) Pharmaceutical form for extended release of active substances
IL252596A0 (en) Azabicyclooctane derivatives as fxr agonists for use in the treatment of liver and gastrointestinal diseases
EP2981612A4 (en) Compositions and methods for in vivo excision of hiv-1 proviral dna
EP3222278A4 (en) Use of azelnidipine in preparing medicinal composition for treating cancers
EP3206706A4 (en) Stable injectable composition of pharmaceutically active agents and process for its preparation
MX2021001231A (en) Heterocyclic compounds and their uses.
EP3235512A4 (en) Method using polyethylene glycol to prepare fibroin nano/microspheres, and application of method in controlled drug release
PH12015502535B1 (en) Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes
CL2015001020A1 (en) Compounds derived from 4-carboxamido-isoindolinone, selective inhibitors of parp-1; Preparation process; pharmaceutical composition; an in vitro method; a product; and its use as a medicine with antineoplastic activity
MX2016011290A (en) Lipoic acid choline ester compositions and methods of use.
PH12015502556A1 (en) Modified release formulation
MX2015012416A (en) Heterocyclic compounds and their uses.
HK1205932A1 (en) Pharmaceutical formulation for bedwetting and method of use thereof
EP3519615A4 (en) Micro-array devices for capturing cells in blood and methods of their use
PL2903608T3 (en) Pharmaceutical composition comprising propionic acid for use in the treatment of viral infections
HK1213891A1 (en) Process for the preparation of voriconazole and analogues thereof
HRP20180781T1 (en) Pharmaceutical composition comprising lacidipine and process of preparation
ZA201400653B (en) Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation
MX2015011101A (en) Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parameters.
GB201412879D0 (en) Formulation and method for the printing of biological materials